Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Hypercholesterolemia”

224 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 224 results

Large-scale testing (Phase 3)Study completedNCT01370603
What this trial is testing

Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)

Who this might be right for
Hypercholesterolemia
Organon and Co 328
Not applicableStudy completedNCT01070966
What this trial is testing

Vytorin Reexamination Study (0653A-174)

Who this might be right for
Primary Hypercholesterolemia and Homozygous Familial Hypercholesterolemia (HoFH)
Organon and Co 2,089
Early research (Phase 1)Study completedNCT06475872
What this trial is testing

Study to Evaluate the Bioequivalence of "Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)" and "Crestor Tablet 5 mg (Rosuvastatin Calcium)" in Healthy Adult Subjects

Who this might be right for
Primary HypercholesterolemiaCombined Hyperlipidemia
Hanlim Pharm. Co., Ltd. 36
Large-scale testing (Phase 3)Study completedNCT00309777
What this trial is testing

Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin

Who this might be right for
HypercholesterolemiaDyslipidemia
Kowa Research Europe 857
Large-scale testing (Phase 3)Active Not RecruitingNCT05739383
What this trial is testing

Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Who this might be right for
Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 14,012
Post-approval studies (Phase 4)Study completedNCT00202904
What this trial is testing

Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)

Who this might be right for
HypercholesterolemiaCoronary Heart Disease
Organon and Co 81
Not applicableStudy completedNCT01930149
What this trial is testing

Promoting Cholesterol Screening

Who this might be right for
Cardiovascular DiseasesLipid TestingPrimary Prevention of Cardiovascular Disease
Northwestern University 480
Large-scale testing (Phase 3)Not Yet RecruitingNCT07421284
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy

Who this might be right for
Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 900
Not applicableStudy completedNCT05118230
What this trial is testing

Study to Assess the Real World Effectiveness of Inclisiran in Chinese Adult Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Novartis Pharmaceuticals 61
Testing effectiveness (Phase 2)Study completedNCT01279590
What this trial is testing

Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)

Who this might be right for
MyalgiaHypercholesterolemiaHyperlipidemia
Furiex Pharmaceuticals, Inc 282
Large-scale testing (Phase 3)Study completedNCT00325780
What this trial is testing

Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia

Who this might be right for
HypercholesterolemiaDyslipidemia
Kowa Research Europe 1,355
Post-approval studies (Phase 4)Study completedNCT00932620
What this trial is testing

Comparison of Simvastatin Versus Simvastatin/Ezetimibe on Small Dense Low -Density Lipoprotein (LDL)

Who this might be right for
Hypercholesterolemia
University of Ioannina 100
Post-approval studies (Phase 4)Study completedNCT00653796
What this trial is testing

Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434)

Who this might be right for
HypercholesterolemiaAtherosclerosis
Organon and Co 148
Not applicableLooking for participantsNCT03989167
What this trial is testing

Clinical Decision Support for Familial Hypercholesterolemia

Who this might be right for
Hypercholesterolemia, FamilialClinical Decision Support
University Hospital, Linkoeping 460,000
Large-scale testing (Phase 3)Study completedNCT04652349
What this trial is testing

Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia

Who this might be right for
Primary Hypercholesterolemia
Hanmi Pharmaceutical Company Limited 279
Post-approval studies (Phase 4)Study completedNCT00650663
What this trial is testing

Ezetimibe Plus Simvastatin Versus Simvastatin Alone in African-American Subjects With Primary Hypercholesterolemia (P03377)

Who this might be right for
HypercholesterolemiaAtherosclerosis
Organon and Co 247
Large-scale testing (Phase 3)Study completedNCT04849000
What this trial is testing

Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage

Who this might be right for
Primary HypercholesterolemiaMixed Hyperlipemia
Jiangsu HengRui Medicine Co., Ltd. 709
Not applicableStudy completedNCT00660764
What this trial is testing

Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)

Who this might be right for
HypercholesterolemiaCoronary Heart DiseasePeripheral Vascular Disease+2 more
AstraZeneca
Large-scale testing (Phase 3)Study completedNCT00101439
What this trial is testing

Evaluate the Effects of Ezetimibe (MK-0653) on the Postprandial (Following a Meal) Lipoprotein Response in Participants With Primary Hypercholesterolemia (High Cholesterol) (MK-0653-072)(COMPLETED)

Who this might be right for
Hypercholesterolemia
Organon and Co 58
Large-scale testing (Phase 3)UnknownNCT04659070
What this trial is testing

To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia

Who this might be right for
Primary HypercholesterolemiaHypertension
Hanlim Pharm. Co., Ltd. 156
Load More Results